Insulin-Like Growth Factor I Synergizes with Interleukin 4 for Hematopoietic Cell Proliferation Independent of Insulin Receptor Substrate Expression

REFERENCES

• Amati, B., T. D. Littlewood, G. I. Evan, and J. Land 1993. The c-Myc protein induces cell cycle progression and apoptosis through dimerization with Max. EMBO J. 12:5083–5087.
   PubMed Web of Science ®Google Scholar
• Baserga, R. 1995. The insulin-like growth factor I receptor: a key to tumor growth. Cancer Res. 55:249–252.
   PubMed Web of Science ®Google Scholar
• Baserga, R., A. Hongo, M. Rubini, M. Prisco, and J. Valentinis 1997. The IGF-I receptor in cell growth, transformation and apoptosis. Biochim. Biophys. Acta 1332:F105–F126.
   PubMed Web of Science ®Google Scholar
• Blakesley, V. A., A. Scrimgeour, D. Esposito, and J. LeRoith 1996. Signaling via the insulin-like growth factor-I receptor: does it differ from insulin receptor signaling? Cytokine Growth Factor Rev. 7:153–159.
   PubMedGoogle Scholar
• Bolland, S., R. N. Pearse, T. Kurosaki, and J. Ravetch 1998. SHIP modulates immune receptor responses by regulating membrane association of Btk. Immunity 8:509–516.
   PubMed Web of Science ®Google Scholar
• Boney, C. M., R. M. Smith, and J. Gruppuso 1998. Modulation of insulin-like growth factor I mitogenic signaling in 3T3-L1 preadipocyte differentiation. Endocrinology 139:1638–1644.
   PubMed Web of Science ®Google Scholar
• Bonfini, L., E. Migliaccio, G. Pelicci, L. Lanfrancone, and J. Pelicci 1996. Not all Shc’s roads lead to Ras. Trends Biochem. Sci. 21:257–261.
   PubMed Web of Science ®Google Scholar
• Burgaud, J. L., M. Resnicoff, and J. Baserga 1995. Mutant IGF-I receptors as dominant negatives for growth and transformation. Biochem. Biophys. Res. Commun. 214:475–481.
   PubMedGoogle Scholar
• Conover, C. A., and J. Bale 1998. Insulin-like growth factor I induction of c-myc expression in bovine fibroblasts can be blocked by antecedent insulin receptor activation. Exp. Cell Res. 238:122–127.
   PubMedGoogle Scholar
• Damen, J. E., L. Liu, P. Rosten, R. K. Humphries, A. B. Jefferson, P. W. Majerus, and J. Krystal 1996. The 145-kDa protein induced to associate with Shc by multiple cytokines is an inositol tetraphosphate and phosphatidylinositol 3,4,5-triphosphate 5-phosphatase. Proc. Natl. Acad. Sci. USA 93:1689–1693.
   PubMed Web of Science ®Google Scholar
• Downward, J. 1996. Control of ras activation. Cancer Surv. 27:87–100.
   PubMedGoogle Scholar
• Gustafson, T. A., W. He, A. Craparo, C. D. Schaub, and J. O’Neill 1995. Phosphotyrosine-dependent interaction of SHC and insulin receptor substrate 1 with the NPEY motif of the insulin receptor via a novel non-SH2 domain. Mol. Cell. Biol. 15:2500–2508.
   PubMed Web of Science ®Google Scholar
• Harada, S., R. M. Smith, J. A. Smith, M. F. White, and J. Jarett 1996. Insulin-induced egr-1 and c-fos expression in 32D cells requires insulin receptor, Shc, and mitogen-activated protein kinase, but not insulin receptor substrate-1 and phosphatidylinositol 3-kinase activation. J. Biol. Chem. 271:30222–30226.
   PubMedGoogle Scholar
• He, W., A. Craparo, Y. Zhu, T. J. O’Neill, L. M. Wang, J. H. Pierce, and J. Gustafson 1996. Interaction of insulin receptor substrate-2 (IRS-2) with the insulin and insulin-like growth factor I receptors. Evidence for two distinct phosphotyrosine-dependent interaction domains within IRS-2. J. Biol. Chem. 271:11641–11645.
   PubMed Web of Science ®Google Scholar
• He, W., T. J. O’Neill, and J. Gustafson 1995. Distinct modes of interaction of SHC and insulin receptor substrate-1 with the insulin receptor NPEY region via non-SH2 domains. J. Biol. Chem. 270:23258–23262.
   PubMedGoogle Scholar
• Ishihara, H., T. Sasaoka, M. Ishiki, Y. Takata, T. Imamura, I. Usui, W. J. Langlois, T. Sawa, and J. Kobayashi 1997. Functional importance of Shc tyrosine 317 on insulin signaling in Rat1 fibroblasts expressing insulin receptors. J. Biol. Chem. 272:9581–9586.
   PubMedGoogle Scholar
• Jiang, Y., J. L.-K. Chan, C. S. Zong, and J. Wang 1996. Effect of tyrosine mutations on the kinase activity and transforming potential of an oncogenic human insulin-like growth factor I receptor. J. Biol. Chem. 271:160–167.
   PubMedGoogle Scholar
• Keegan, A. D., K. Nelms, L. M. Wang, J. H. Pierce, and J. Paul 1994. Interleukin 4 receptor: signaling mechanisms. Immunol. Today 15:423–432.
   PubMedGoogle Scholar
• Keegan, A. D., K. Nelms, M. White, L. M. Wang, J. H. Pierce, and J. Paul 1994. An IL-4 receptor region containing an insulin receptor motif is important for IL-4-mediated IRS-1 phosphorylation and cell growth. Cell 76:811–820.
   PubMed Web of Science ®Google Scholar
• Lavan, B. E., V. R. Fantin, E. T. Chang, W. S. Lane, S. R. Keller, and J. Lienhard 1997. A novel 160-kDa phosphotyrosine protein in insulin-treated embryonic kidney cells is a new member of the insulin receptor substrate family. J. Biol. Chem. 272:21403–21407.
   PubMed Web of Science ®Google Scholar
• Li, W., Y.-X. Jiang, J. Zhang, L. Soon, L. Flechner, V. Kapoor, J. H. Pierce, and J. Wang 1998. Protein kinase C-δ is an important signaling molecule in insulin-like growth factor I receptor-mediated cell transformation. Mol. Cell. Biol. 18:5888–5898.
   PubMedGoogle Scholar
• Li, W., J.-C. Yu, P. Michieli, J. F. Beeler, N. Ellmore, M. A. Heidaran, and J. Pierce 1994. Stimulation of the platelet-derived growth factor β receptor signaling pathway activates protein kinase C-δ. Mol. Cell. Biol. 14:6727–6735.
   PubMedGoogle Scholar
• Li, W. Unpublished observations.
   Google Scholar
• Lioubin, M. N., P. A. Algate, S. Tsai, K. Carlberg, A. Aebersold, and J. Rohrschneider 1996. p150Ship, a signal transduction molecule with inositol polyphosphate-5-phosphatase activity. Genes Dev. 10:1084–1095.
   PubMed Web of Science ®Google Scholar
• Lioubin, M. N., G. M. Myles, K. Carlberg, D. Bowtell, and J. Rohrschneider 1994. Shc, Grb2, Sos1, and a 150-kilodalton tyrosine-phosphorylated protein form complexes with Fms in hematopoietic cells. Mol. Cell. Biol. 14:5682–5691.
   PubMed Web of Science ®Google Scholar
• Liu, D., W. J. Rutter, and J. Wang 1992. Enhancement of transforming potential of human insulin-like growth factor I receptor by N-terminal truncation and fusion to avian sarcoma virus. J. Virol. 66:374–385.
   PubMedGoogle Scholar
• Liu, D., W. J. Rutter, and J. Wang 1993. Modulatory effects of the extracellular sequence of the human insulin-like growth I receptor on its transforming and tumorigenic potential. J. Virol. 67:9–18.
   PubMedGoogle Scholar
• Mischak, H., J. H. Pierce, J. Goodnight, M. G. Kazanietz, P. M. Blumberg, and J. Mushinski 1993. Phorbol ester-induced myeloid differentiation is mediated by protein kinase C-α and -δ and not protein kinase C-βII, -γ, -ζ, and -η. J. Biol. Chem. 268:20110–20115.
   PubMed Web of Science ®Google Scholar
• Myers, M. G. Jr., Y. Zhang, G. A. Aldaz, T. Grammer, E. M. Glasheen, L. Yenush, L. M. Wang, X. J. Sun, J. Blenis, J. H. Pierce, and J. White 1996. YMXM motifs and signaling by an insulin receptor substrate 1 molecule without tyrosine phosphorylation sites. Mol. Cell. Biol. 16:4147–4155.
   PubMed Web of Science ®Google Scholar
• Okajima, Y., I. Matsumura, T. Nishiura, K. Hashimoto, H. Yoshida, J. Ishikawa, H. Wakao, A. Yoshimura, Y. Kanakura, Y. Tomiyama, and J. Matsuzawa 1998. Insulin-like growth factor-I augments erythropoietin-induced proliferation through enhanced tyrosine phosphorylation of STAT5. J. Biol. Chem. 273:22877–22883.
   PubMedGoogle Scholar
• O’Neill, T. J., A. Craparo, and J. Gustafson 1994. Characterization of an interaction between insulin receptor substrate 1 and the insulin receptor by using the two-hybrid system. Mol. Cell. Biol. 14:6433–6442.
   PubMedGoogle Scholar
• Ono, M., S. Bolland, P. Tempst, and J. Ravetch 1996. Role of the inositol phosphatase SHIP in negative regulation of the immune system by the receptor Fc(gamma)RIIB. Nature 383:263–266.
   PubMed Web of Science ®Google Scholar
• Patel, B. K., L. M. Wang, C. C. Lee, W. G. Taylor, J. H. Pierce, and J. LaRochelle 1996. Stat6 and Jak1 are common elements in platelet-derived growth factor and interleukin-4 signal transduction pathways in NIH 3T3 fibroblasts. J. Biol. Chem. 271:22175–22182.
   PubMed Web of Science ®Google Scholar
• Patel, B. K. R., J. H. Pierce, and J. LaRochelle 1998. Regulation of interleukin 4-mediated signaling by naturally occurring dominant negative and attenuated forms of human Stat6. Proc. Natl. Acad. Sci. USA 95:172–177.
   PubMedGoogle Scholar
• Paul, W. E. 1997. Interleukin 4: signalling mechanisms and control of T cell differentiation. Ciba Found. Symp. 204:208–216.
   PubMedGoogle Scholar
• Pernis, A., B. Witthuhn, A. D. Keegan, K. Nelms, E. Garfein, J. N. Ihle, W. E. Paul, J. H. Pierce, and J. Rothman 1995. Interleukin 4 signals through two related pathways. Proc. Natl. Acad. Sci. USA 92:7971–7975.
   PubMed Web of Science ®Google Scholar
• Prisco, M., A. Hongo, M. G. Rizzo, A. Sacchi, and J. Baserga 1997. The insulin-like growth factor I receptor as a physiologically relevant target of p53 in apoptosis caused by interleukin-3 withdrawal. Mol. Cell. Biol. 17:1084–1092.
   PubMedGoogle Scholar
• Roussel, M. F., J. L. Cleveland, S. A. Shurtleff, and J. Sherr 1991. Myc rescue of a mutant CSF-1 receptor impaired in mitogenic signalling. Nature 353:361–363.
   PubMed Web of Science ®Google Scholar
• Sasaoka, T., M. Ishiki, T. Sawa, H. Ishihara, Y. Takata, T. Imamura, I. Usui, J. M. Olefsky, and J. Kobayashi 1996. Comparison of the insulin and insulin-like growth factor 1 mitogenic intracellular signaling pathways. Endocrinology 137:4427–4434.
   PubMed Web of Science ®Google Scholar
• Skolnik, E. Y., A. Batzer, N. Li, C. H. Lee, E. Lowenstein, M. Mohammadi, B. Margolis, and J. Schlessinger 1993. The function of GRB2 in linking the insulin receptor to Ras signaling pathways. Science 260:1953–1955.
   PubMed Web of Science ®Google Scholar
• Sun, X. J., L. M. Wang, Y. Zhang, L. Yenush, M. G. Myers Jr., E. Glasheen, W. S. Lane, J. H. Pierce, and J. White 1995. Role of IRS-2 in insulin and cytokine signalling. Nature 377:173–177.
   PubMed Web of Science ®Google Scholar
• Ullrich, A., A. Gray, R. W. Tam, T. Yang-Feng, M. Tsubokawa, C. Collins, W. Henzel, T. Le Bon, S. Kathuria, E. Chen, S. Jacobs, U. Franke, J. Ramachandran, and J. Fujita-Yamaguchi 1986. Insulin-like growth factor I receptor primary structure: comparison with insulin receptor suggests structural determinants that define functional specificity. EMBO J. 5:2503–2512.
   PubMed Web of Science ®Google Scholar
• Ullrich, A., and J. Schlessinger 1990. Signal transduction by receptors with tyrosine kinase activity. Cell 61:203–211.
   PubMed Web of Science ®Google Scholar
• Wang, L.-M., A. D. Keegan, W. Li, G. E. Lienhard, S. Pacini, J. S. Gutkind, M. G. Myers Jr., M. F. Whiter, S. A. Aaronson, W. E. Paul, and J. Pierce 1993. Common elements in interleukin 4 and insulin signaling pathways in factor-dependent hematopoietic cells. Proc. Natl. Acad. Sci. USA 90:4032–4036.
   PubMed Web of Science ®Google Scholar
• Wang, L. M., A. Keegan, M. Frankel, W. E. Paul, and J. Pierce 1995. Signal transduction through the IL-4 and insulin receptor families. Stem Cells (Dayton) 13:360–368.
   PubMedGoogle Scholar
• Wang, L. M., M. G. Myers Jr., X. J. Sun, S. A. Aaronson, M. White, and J. Pierce 1993. IRS-1: essential for insulin- and IL-4-stimulated mitogenesis in hematopoietic cells. Science 261:1591–1594.
   PubMedGoogle Scholar
• Wery, S., M. Letourneur, J. Bertoglio, and J. Pierre 1996. Interleukin-4 induces activation of mitogen-activated protein kinase and phosphorylation of shc in human keratinocytes. J. Biol. Chem. 271:8529–8532.
   PubMed Web of Science ®Google Scholar
• White, M. F. 1997. The insulin signalling system and the IRS proteins. Diabetologia 40 (Suppl. 2):S2–S17.
   PubMedGoogle Scholar
• White, M. F., and J. Yenush 1998. The IRS-signaling system: a network of docking proteins that mediate insulin and cytokine action. Curr. Top. Microbiol. Immunol. 228:179–208.
   PubMed Web of Science ®Google Scholar
• Yang, Y., H. M. Yoo, I. Choi, K. H. Pyun, S. M. Byun, and J. Ha 1996. Interleukin 4-induced proliferation in normal human keratinocytes is associated with c-myc gene expression and inhibited by genistein. J. Investig. Dermatol. 107:367–372.
   PubMedGoogle Scholar
• Yu, J.-C., J. S. Gutkind, D. Mahadevan, W. Li, K. A. Meyer, J. H. Pierce, and J. Heidaran 1994. Biological function of PDGF-induced PI-3K activity: its role in αPDGF receptor-mediated mitogenic signaling. J. Cell Biol. 127:479–487.
   PubMedGoogle Scholar
• Zhou-Li, F., S. Q. Xu, M. Dews, and J. Baserga 1997. Co-operation of simian virus 40 T antigen and insulin receptor substrate-1 in protection from apoptosis induced by interleukin-3 withdrawal. Oncogene 15:961–970.
   PubMedGoogle Scholar